Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Top Ten Searches
post partum incontinence fibroid hpv colpotomy ovarian cyst curettage endometriosis intrauterine umbilical cordYour Article Summary
Randomized Comparison of Fluorouracil Plus Cisplatin vs. Cisplatin as an Adjunct to Radiation Therapy in Stage IIB- IVA Squamous Cell Carcinoma of the Cervix: Pilot Study
Journal of The Medical Association of Thailand, 08/13/09
Sukhaboon J et al. – To compare the efficacy and toxicity of pelvic radiotherapy with concomitant cisplatin plus fluorouracil versus cisplatin alone in patients with locally advanced squamous cell cervical cancer. No difference was found in the response rate, but higher frequencies of hemotological adverse effects in the cisplatin group.
Related Articles
Hormone Therapy Can Help Some with Prostate Cancer
MedLinePlus, 11/04/09
Relevance Score: 69%
Systematic Review: Charged-Particle Radiation Therapy for Cancer
Annals of Internal Medicine, 10/20/09
Relevance Score: 69%
Is Radiation Therapy for Keloids Acceptable? The Risk of Radiation-Induced Carcinogenesis
Plastic and Reconstructive Surgery, 10/12/09
Relevance Score: 69%
Radiation therapy for early breast cancer
Clinical and Translational Oncology, 10/07/09
Relevance Score: 69%
Shorter Radiation Course Stops Cancer Growth In High-risk Prostate Cancer Patients
ScienceDaily, 11/12/09
Relevance Score: 68%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Suppression of follicular rupture with meloxicam, a cyclooxygenase-2 inhibitor: potential for emergency contraception
Human Reproduction, 11/24/09
The rationale for mTOR inhibition in epithelial ovarian cancer
Expert Opinion on Investigational Drugs, 11/24/09
Factors contributing to gender differences in serum retinol and -tocopherol in infertile couples
Reproductive BioMedicine Online, 11/24/09
Today in Gynecologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Paracentesis in Ovarian Cancer: A Study of the Physiology during Free Drainage of Ascites
Journal of Palliative Medicine, 11/25/09
How to deal with prognostic factors and radiotherapy results in uterine neoplasms with a sarcomatous component
Clinical and Translational Oncology, 11/25/09
Chemotherapy intensity and toxicity among black and white women with advanced and recurrent endometrial cancer
Cancer, 11/25/09
Sponsor
Article Search
Sponsor


See Latest Articles


